PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. has been the subject of 205 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles.
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.: 0 warning letters, 205 recalls, 0 approval records, 0 Form 483s.
Side by side
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles — Warning letters0
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. — Warning letters0
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles — Recalls1
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. — Recalls205
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles — Approval records0
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. — Approval records0
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles — Form 483s0
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. — Form 483s0
Timeline
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles
Most recent FDA action: May 13, 2026
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/central-admixture-pharmacy-services-inc-caps-los-angeles-vs-philips-medical-systems-nederland-b-v
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗